Pathologic complete response after photodynamic therapy combined with dose-reduction chemoradiotherapy in elderly patient with severe obstruction esophageal carcinoma: A case report

Photodiagnosis Photodyn Ther. 2023 Mar:41:103274. doi: 10.1016/j.pdpdt.2023.103274. Epub 2023 Jan 5.

Abstract

Esophageal Carcinoma (EC) is one of the most aggressive gastrointestinal cancers. Advanced esophageal carcinoma is associated mainly with dysphagia which reduces the quality of life and leads to frail in patients even difficult to tolerate systemic treatments such as surgery and chemoradiotherapy. Moreover, chemoradiotherapy(CRT)cannot relieve dysphagia in a short time especially for the elderly patient with comorbidities. Here, we report a 76-year-old female patient diagnosed with severe obstructive esophageal squamous cell carcinoma (ESCC) that endoscope could not pass through. She was also complicated with bilateral interstitial pneumonia and moderate pulmonary ventilation dysfunction. The patient was unable to undergo surgery and radical CRT. After multidisciplinary team (MDT) discussion, we gave the patient photodynamic therapy (PDT) treatment firstly. The obstruction was significantly improved within 1 week and normal diet was resumed after 2 weeks. Four weeks later, considering bilateral interstitial pneumonia, concurrent dose-reduction chemoradiotherapy was given for esophageal lesions and abdominal metastatic lymph nodes. There was no recurrence and progression in the esophagus and abdominal lymph nodes until now and the biopsy of the primary esophageal lesion showed pathologic complete response. Now, the patient is still under regular follow-up.

Keywords: Chemoradiotherapy; Elderly; Esophageal carcinoma; Obstruction; Photodynamic therapy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Squamous Cell* / drug therapy
  • Chemoradiotherapy
  • Deglutition Disorders* / drug therapy
  • Deglutition Disorders* / etiology
  • Esophageal Neoplasms* / complications
  • Esophageal Neoplasms* / drug therapy
  • Esophageal Squamous Cell Carcinoma* / drug therapy
  • Esophageal Squamous Cell Carcinoma* / pathology
  • Female
  • Humans
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use
  • Quality of Life

Substances

  • Photosensitizing Agents